Telcagepant provides new hope for people with migraine

Research output: Contribution to journalDebate/Note/Editorial

Abstract

The triptan drugs provide effective migraine relief for many people. nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also lead to an array of adverse effects. A new class of antimigraine drugs, currently undergoing clinical trials, could offer hope to those for whom triptan medication is unsuitable.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology
Original languageEnglish
Pages (from-to)240-242
JournalNature Reviews Neurology
Volume5
Issue number5
Publication statusPublished - 2009
Publication categoryResearch
Peer-reviewedNo